Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alphabet Inc Class A (GOOGL) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

Alphabet Inc Class ATrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Alphabet Inc Class A vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Alphabet Inc Class A trades at $342.26 (market cap $4.30T), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Alphabet Inc Class A is far larger — about 1028.7× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Alphabet Inc Class A pays a 0.25% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alphabet Inc Class A for 86 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

GOOGLINDV
Market Cap
$4.30T$4.18B
Volume
22,270,2891,819,746
Sector
MediaHealth
52-Week High
$402.62$41.83
52-Week Low
$250.46$24.09
Typical Hold Time
86 Days0 Days
Enterprise Value
$4.19T$4.47B
Dividend Yield
0.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alphabet Inc Class A

Alphabet (GOOGL) trades at $347.64, down 1.44% today, but maintains strong technical support near $344-$350. The company demonstrates robust fundamentals with 2025 revenue of $402.84B and net income of $132.17B, achieving a 54.77% net margin. Recent earnings beats and strong analyst consensus support the bullish outlook, with 87% of analysts rating it a Buy. Technical indicators show bullish moving averages but overbought RSI conditions.

Alphabet presents a compelling investment case with strong AI-driven growth, consistent earnings outperformance, and dominant market positioning. Key risks include regulatory scrutiny, competitive pressures in AI, and market volatility. With a consensus price target of $430.96 representing 24% upside potential, the stock offers attractive long-term value despite short-term technical overbought conditions.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GOOGL
22% Buy78% Sell
Avg holding period · 86 Days
INDV
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

Read more on GOOGL →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →